VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $34,000 | -97.9% | 1,446 | -98.6% | 0.00% | -98.3% |
| Q1 2018 | $1,615,000 | -61.7% | 101,446 | -50.0% | 0.06% | -22.4% |
| Q4 2017 | $4,216,000 | +190.0% | 202,892 | +100.0% | 0.08% | +46.2% |
| Q3 2017 | $1,454,000 | -17.2% | 101,446 | 0.0% | 0.05% | -14.8% |
| Q2 2017 | $1,755,000 | +524.6% | 101,446 | +298.3% | 0.06% | +577.8% |
| Q1 2017 | $281,000 | -24.1% | 25,471 | 0.0% | 0.01% | -18.2% |
| Q4 2016 | $370,000 | -60.7% | 25,471 | -33.6% | 0.01% | -59.3% |
| Q3 2016 | $941,000 | -37.9% | 38,346 | -49.0% | 0.03% | -38.6% |
| Q2 2016 | $1,515,000 | +1047.7% | 75,246 | +1404.9% | 0.04% | +1000.0% |
| Q1 2016 | $132,000 | -78.3% | 5,000 | -16.7% | 0.00% | -78.9% |
| Q4 2015 | $607,000 | -70.2% | 6,000 | -34.7% | 0.02% | -75.0% |
| Q2 2015 | $2,039,000 | +496.2% | 9,190 | +431.5% | 0.08% | +484.6% |
| Q1 2015 | $342,000 | -58.5% | 1,729 | -69.9% | 0.01% | -65.8% |
| Q4 2014 | $825,000 | +15.1% | 5,742 | +5.1% | 0.04% | +31.0% |
| Q3 2014 | $717,000 | +0.4% | 5,463 | -3.1% | 0.03% | +3.6% |
| Q2 2014 | $714,000 | -22.9% | 5,638 | -19.8% | 0.03% | -26.3% |
| Q1 2014 | $926,000 | -35.8% | 7,030 | -42.8% | 0.04% | -37.7% |
| Q4 2013 | $1,443,000 | – | 12,299 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |